Heart Failure News and Research

RSS
Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.
Wearable health trackers reveal how accurate your smartwatch really is

Wearable health trackers reveal how accurate your smartwatch really is

Study shows sharp increase in kidney disease deaths linked to high blood pressure

Study shows sharp increase in kidney disease deaths linked to high blood pressure

Sacubitril/valsartan shows benefit over enalapril in heart failure caused by Chagas disease

Sacubitril/valsartan shows benefit over enalapril in heart failure caused by Chagas disease

Flooding from Hurricane Sandy raises heart disease risk years later

Flooding from Hurricane Sandy raises heart disease risk years later

Study reveals how type 2 diabetes directly alters the heart’s structure and energy systems

Study reveals how type 2 diabetes directly alters the heart’s structure and energy systems

Faster progression to severe diabetes observed in people with learning disabilities

Faster progression to severe diabetes observed in people with learning disabilities

Walking faster may protect your bones and prevent fractures

Walking faster may protect your bones and prevent fractures

Revascularization strategy fails to show noninferiority in STEMI patients

Revascularization strategy fails to show noninferiority in STEMI patients

Heart failure hospitalization occurs earlier in Black and Hispanic adults than white patients

Heart failure hospitalization occurs earlier in Black and Hispanic adults than white patients

New hypothesis links internal fat biology to heart failure with preserved ejection fraction

New hypothesis links internal fat biology to heart failure with preserved ejection fraction

In-hospital start of dapagliflozin shows no significant short-term benefit in heart failure patients

In-hospital start of dapagliflozin shows no significant short-term benefit in heart failure patients

Baxdrostat offers hope for millions with difficult-to-control high blood pressure

Baxdrostat offers hope for millions with difficult-to-control high blood pressure

Ivabradine fails to prevent myocardial injury after noncardiac surgery in large clinical trial

Ivabradine fails to prevent myocardial injury after noncardiac surgery in large clinical trial

Trial shows no meaningful gains with mavacamten in nonobstructive hypertrophic cardiomyopathy

Trial shows no meaningful gains with mavacamten in nonobstructive hypertrophic cardiomyopathy

Vericiguat reduces mortality and hospitalizations in a broad range of patients with HFrEF

Vericiguat reduces mortality and hospitalizations in a broad range of patients with HFrEF

New trial shows benefit of digitoxin in patients with severe heart failure symptoms

New trial shows benefit of digitoxin in patients with severe heart failure symptoms

Beta blockers reduce mortality and heart failure in MI patients with mildly reduced ejection fraction

Beta blockers reduce mortality and heart failure in MI patients with mildly reduced ejection fraction

ESC releases new guidance on lipid management to reduce cardiovascular risk

ESC releases new guidance on lipid management to reduce cardiovascular risk

New ESC guidelines prioritize women's autonomy in high-risk pregnancies

New ESC guidelines prioritize women's autonomy in high-risk pregnancies

REBOOT trial finds no benefit of beta blockers after uncomplicated heart attacks

REBOOT trial finds no benefit of beta blockers after uncomplicated heart attacks

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.